News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|July 24, 2024

Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

Author(s)Ryan Haumschild, PharmD, MS, MBA, Jamie L. Koprivnikar, MD, David Dingli, MD, PhD

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.

Episodes in this series

EP. 1 PNH Overview and Pathophysiology

EP. 1 PNH Overview and Pathophysiology

EP. 2 Intravascular and Extravascular Hemolysis MoA in PNH

EP. 2 Intravascular and Extravascular Hemolysis MoA in PNH

EP. 3 Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming

EP. 3 Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming

EP. 4 Key Treatment Considerations for Patients Diagnosed With PNH

EP. 4 Key Treatment Considerations for Patients Diagnosed With PNH

EP. 5 Complement System Role in PNH Treatment Approach

EP. 5 Complement System Role in PNH Treatment Approach

EP. 6 Eculizumab Impact on PNH Treatment Landscape and Unmet Needs in PNH Management

EP. 6 Eculizumab Impact on PNH Treatment Landscape and Unmet Needs in PNH Management

EP. 7 Efficacy End Points For PNH Treatment

EP. 7 Efficacy End Points For PNH Treatment

EP. 8 Efficacy and Safety Trials Results of Complement Inhibitors

EP. 8 Efficacy and Safety Trials Results of Complement Inhibitors

EP. 9 Treatment Adherence and Cost Considerations Surrounding Various Routes of PNH Treatment Administration

EP. 9 Treatment Adherence and Cost Considerations Surrounding Various Routes of PNH Treatment Administration

EP. 10 Investigational Therapies Paving New PNH Treatment Pathways

EP. 10 Investigational Therapies Paving New PNH Treatment Pathways

EP. 11 Key Financial Factors Associated With Typical PNH Treatment Journey

EP. 11 Key Financial Factors Associated With Typical PNH Treatment Journey

EP. 12 Navigating Transfusion Requirements in PNH Treatment

EP. 12 Navigating Transfusion Requirements in PNH Treatment

EP. 13 Considerations for Managing PNH Treatment Complications

EP. 13 Considerations for Managing PNH Treatment Complications

EP. 14 Infection Risk Management Counseling For Patients Receiving Treatment for PNH

EP. 14 Infection Risk Management Counseling For Patients Receiving Treatment for PNH

A panel of 4 experts on PNH

EP. 15 Ensuring PNH Treatment Access and Adherence to Therapies

A panel of 4 experts on PNH

EP. 16 Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

Video content above is prompted by the following question:

How do financial considerations influence your treatment decision-making process?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Andrew T. Kuykendall, MD, associate member in the Department of Hematology at Moffitt Cancer Center and lead investigator for VERIFY | Image: Moffitt

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

August 29th 2026

Kerry Rogers, MD | Image Credit: © The James

The Struggle Is Real for CAR T-Cell Therapy: Kerry Rogers, MD

ByKerry Rogers, MD,Maggie L. Shaw

August 29th 2026

Thrombosis | Image Credit: freshidea - stock.adobe.com

Thromboembolic Risk Remains High Across Polycythemia Vera Groups

ByMaggie L. Shaw

August 27th 2026

Chroniclymphocyticleukemia | Image Credit: © Saiful52-stock.adobe.com

Zanubrutinib Shows Longer PFS Than FCR in CLL

ByMaggie L. Shaw

August 26th 2026

Xavier Leleu, MD, PhD

Innovative Sub-Q Method Could Transform MM Care: Xavier Leleu, MD, PhD

ByXavier Leleu, MD, PhD,Maggie L. Shaw

August 26th 2026

Trending on AJMC

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk